Zobrazeno 1 - 10
of 21
pro vyhledávání: '"N B, Rostova"'
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 2, Pp 198-205 (2023)
Introduction. Providing high-quality, effective and safe drugs intended for the treatment of rare (orphan) diseases among the population of the Member States of the Union is one of the most significant and promising development vectors for manufactur
Externí odkaz:
https://doaj.org/article/d94b3f509a034842b77177f5cd97dd1a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 133-138 (2022)
Introduction. New requirements for the registration of generic drugs after the entry of the Russian Federation into the Eurasian Economic Union (EAEU) and the signing of the Agreement on Common Principles and Rules for the Circulation of Medicinal Pr
Externí odkaz:
https://doaj.org/article/d8b6d93e09314d44add9d12539fc85d5
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 1, Pp 159-164 (2022)
Introduction. An important task for pharmaceutical manufacturers is to bring high quality, effective and safe medicines to the market. In the event that the country's resources are not enough, drugs that have been successfully registered in other cou
Externí odkaz:
https://doaj.org/article/aad5f9ff7a2246359f4c3d9ef50685bb
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 2, Pp 155-161 (2021)
Introduction. One of the main business objectives of Russian pharmaceutical companies is export development. To obtain marketing authorization in countries with a good potential for business it is of greater importance to be competent in drugs regist
Externí odkaz:
https://doaj.org/article/6ea44726562441d98ea3052e1c783748
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 4, Pp 171-179 (2020)
Introduction. At the stage of transition from national to a uniform of circulation of pharmaceutical products regulation at the Eurasian Economic Union (EAEU) framework, harmonization of requirements for the development of medicines determines the ne
Externí odkaz:
https://doaj.org/article/37c6189826c84d74a878a96e60244b67
Autor:
N. B. Rostova, N. A. Gudilina
Publikováno v:
Вопросы вирусологии, Vol 63, Iss 1, Pp 41-47 (2018)
Results of evaluation of the impact of drugs on indicators of clinical laboratory diagnostics as a criterion of safety of therapy are presented. Antiretroviral therapy for HIV infection was chosen as an example. Information from official sources (sum
Externí odkaz:
https://doaj.org/article/a146775dd7b84712bae4de2617d1c1fb
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 4, Pp 171-179 (2020)
Introduction. At the stage of transition from national to a uniform of circulation of pharmaceutical products regulation at the Eurasian Economic Union (EAEU) framework, harmonization of requirements for the development of medicines determines the ne
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29(6)
The medication support of patients with rare (orphan) diseases is an actual issue, since it requires significant financial costs due to high price of medications. The accessibility of these medications to such patients should be regulated by state in
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29(4)
The article considers such new approaches to information maintenance of medicinal preparation in package as requirements for presentation of information, its location according its importance, availability of warning information. The article focuses
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 28(6)
The purpose of the study was to determine potential availability of anti-retrovirus therapy and to justify proposals for selecting and prescribing rational combining of anti-retrovirus medications for HIV treatment. The objects of the study were anti